World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
45
Citations
8640
World Ranking
4985
National Ranking
146

Hugues Charest publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Hugues Charest sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 105 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Hugues Charest D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Hugues Charest sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 45 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Hugues Charest is affiliated with the University of Montreal in Canada. Their primary field of study is Medicine, with a focus on several subfields including Infectious Diseases, Epidemiology, Molecular Biology, Modeling and Simulation, and Virology.

Their research topics predominantly cover various aspects of viral infections and epidemiology, specifically:

  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research
  • Influenza Virus Research Studies
  • SARS-CoV-2 detection and testing
  • COVID-19 Clinical Research Studies
  • Viral Infections and Outbreaks Research
  • COVID-19 epidemiological studies

Hugues Charest has contributed to several recent publications, including:

  • "Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories," 2020, Journal of Clinical Virology
  • "Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2," 2021, Journal of Biological Chemistry
  • "2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)," 2024, Eurosurveillance
  • "Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada," 2020, The Journal of Infectious Diseases
  • "Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23," 2023, Eurosurveillance

The frequent co-authors they have collaborated with include:

  • Gaston De Serres
  • Danuta M. Skowronski
  • Sara Carazo
  • Judith Fafard
  • Michel Roger

The regular publication venues where their work appears include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Eurosurveillance
  • Clinical Infectious Diseases
  • Journal of Clinical Virology
  • The Journal of Infectious Diseases

Best Publications

  • In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas.

    Caetano Reis e Sousa;Sara Hieny;Tanya Scharton-Kersten;Dragana Jankovic

  • High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

    Bluma G Brenner;Michel Roger;Jean-Pierre Routy;Daniela Moisi

  • Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

    Danuta M. Skowronski;Naveed Z. Janjua;Gaston De Serres;Suzana Sabaiduc

  • Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada

    Danuta M. Skowronski;Gaston De Serres;Natasha S. Crowcroft;Naveed Z. Janjua

  • Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection

    Eduardo Antonio Ferraz Coelho;Carlos Alberto Pereira Tavares;Fernando Aécio Amorim Carvalho;Karina Figueiredo Chaves

  • Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells

    Julio Aliberti;Jesus G. Valenzuela;Vern B. Carruthers;Sara Hieny

  • Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii.

    E Y Denkers;G Yap;T Scharton-Kersten;H Charest

  • Decreased Resistance of TNF Receptor p55- and p75-Deficient Mice to Chronic Toxoplasmosis Despite Normal Activation of Inducible Nitric Oxide Synthase In Vivo

    George S. Yap;Tanya Scharton-Kersten;Hugues Charest;Alan Sher

  • Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene.

    H Charest;G Matlashewski

  • The Developmental Expression of Leishmania donovani A2 Amastigote-specific Genes Is Post-transcriptionally Mediated and Involves Elements Located in the 3′-Untranslated Region

    Hugues Charest;Wen-Wei Zhang;Greg Matlashewski

  • Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015

    Danuta M. Skowronski;Catharine Chambers;Gaston De Serres;Suzana Sabaiduc

  • Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani

    Wen Wei Zhang;Hugues Charest;Elodie Ghedin;Greg Matlashewski

  • Component-Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007

    Danuta M. Skowronski;Gaston De Serres;Jim Dickinson;Martin Petric

  • Transmission networks of drug resistance acquired in primary/early stage HIV infection.

    Bluma G Brenner;Michel Roger;Daniela D Moisi;Maureen Oliveira

  • Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009

    Danuta M Skowronski;Naveed Z Janjua;Gaston De Serres;Travis S Hottes

  • Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec

    Bluma G. Brenner;Michel Roger;David Stephens;Daniela Moisi

  • Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections.

    Jesse Papenburg;Mariana Baz;Marie-Ève Hamelin;Chantal Rhéaume

  • Influenza A/Subtype and B/Lineage Effectiveness Estimates for the 2011–2012 Trivalent Vaccine: Cross-Season and Cross-Lineage Protection With Unchanged Vaccine

    Danuta M. Skowronski;Naveed Z. Janjua;Suzana Sabaiduc;Gaston De Serres

  • Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories.

    Jason J LeBlanc;Jonathan B Gubbay;Yan Li;Robert Needle

  • A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010–2011 Season

    Danuta M. Skowronski;Naveed Z. Janjua;Gaston De Serres;Anne-Luise Winter

  • Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen.

    Fernando A.A. Carvalho;Hugues Charest;Carlos Alberto P. Tavares;Greg Matlashewski

Frequent Co-Authors

Yan Li
Yan Li Public Health Agency of Canada
Danuta M. Skowronski
Danuta M. Skowronski University of British Columbia
Jonathan B. Gubbay
Jonathan B. Gubbay BC Children's Hospital Foundation
Nathalie Bastien
Nathalie Bastien Public Health Agency of Canada
Mel Krajden
Mel Krajden University of British Columbia
Gaston De Serres
Gaston De Serres Université Laval
Martin Petric
Martin Petric University of British Columbia
Steven J. Drews
Steven J. Drews Canadian Blood Services
Michel Roger
Michel Roger University of Montreal
Greg Matlashewski
Greg Matlashewski McGill University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, exploring related online degrees can open doors to diverse career pathways. For example, becoming a child life specialist involves applying scientific knowledge to support children and families in healthcare settings. This role often requires both specialized training and a strong foundation in biological sciences.

Many prospective students worry about barriers to education caused by past mistakes. Fortunately, there are best degrees for felons that provide flexible, accessible online programs, including in fields related to microbiology and healthcare, enabling them to rebuild their careers with valuable credentials.

Alternatively, students interested in integrating natural health approaches may consider becoming a functional medicine nurse practitioner. This profession blends clinical science with holistic care, and often requires both microbiology understanding and nursing qualifications.

For those intrigued by medical data and healthcare administration, pursuing certification bodies such as a cpc medical coding salary career might be ideal. Certified professional coders play a crucial role by translating medical records into standardized codes, a field increasingly accessible through online education.

Best Scientists Citing Hugues Charest

Trending Scientists

Recently Published Articles